G

Guangdong Marubi Biotechnology Co Ltd
SSE:603983

Watchlist Manager
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Watchlist
Price: 27.68 CNY -6.77% Market Closed
Market Cap: 11.1B CNY
Have any thoughts about
Guangdong Marubi Biotechnology Co Ltd?
Write Note

Net Margin
Guangdong Marubi Biotechnology Co Ltd

12.3%
Current
12%
Average
3.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.3%
=
Net Income
324.4m
/
Revenue
2.6B

Net Margin Across Competitors

Country CN
Market Cap 11.1B CNY
Net Margin
12%
Country FR
Market Cap 176B EUR
Net Margin
15%
Country UK
Market Cap 117.3B GBP
Net Margin
11%
Country IN
Market Cap 5.7T INR
Net Margin
17%
Country UK
Market Cap 34.7B GBP
Net Margin
11%
Country DE
Market Cap 27.7B EUR
Net Margin
8%
Country US
Market Cap 25.1B USD
Net Margin
1%
Country JP
Market Cap 2.9T JPY
Net Margin
5%
Country IN
Market Cap 1.2T INR
Net Margin
-3%
Country IN
Market Cap 909.1B INR
Net Margin
14%
Country US
Market Cap 10.2B USD
Net Margin
12%
No Stocks Found

Guangdong Marubi Biotechnology Co Ltd
Glance View

Market Cap
11.1B CNY
Industry
Consumer products

Guangdong Marubi Biotechnology Co., Ltd. engages in the research, development, design, production, sales and services of cosmetics. The company is headquartered in Guangzhou, Guangdong and currently employs 1,197 full-time employees. The company went IPO on 2019-07-25. The firm's products mainly include eye care products, skin cleansing products, skin care products (cream lotion and mask), make-up products and others. The firm's brands mainly include Maru, Cac and Passional Lover. The firm mainly conducts its businesses in domestic market.

Intrinsic Value
30.03 CNY
Undervaluation 8%
Intrinsic Value
Price
G

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.3%
=
Net Income
324.4m
/
Revenue
2.6B
What is the Net Margin of Guangdong Marubi Biotechnology Co Ltd?

Based on Guangdong Marubi Biotechnology Co Ltd's most recent financial statements, the company has Net Margin of 12.3%.